Efficacy and safety of omeprazole in Japanese patients with nonerosive reflux disease
- 20 September 2008
- journal article
- research article
- Published by Springer Nature in The Esophagus
- Vol. 43 (9) , 670-678
- https://doi.org/10.1007/s00535-008-2214-5
Abstract
There is increasing awareness of nonerosive reflux disease (NERD) as a disease requiring treatment in Japan. This randomized, double-blind, placebo-controlled, parallel-group study was conducted to investigate the efficacy and safety of omeprazole 10 mg and 20 mg once daily in Japanese patients with NERD.Keywords
This publication has 29 references indexed in Scilit:
- The pharmacodynamic effect of omeprazole 10 mg and 20 mg once daily in patients with nonerosive reflux disease in JapanThe Esophagus, 2006
- Functional Gastroduodenal DisordersGastroenterology, 2006
- Functional Esophageal DisordersGastroenterology, 2006
- Efficacy of Rabeprazole in the Treatment of Symptomatic Gastroesophageal Reflux DiseaseDigestive Diseases and Sciences, 2005
- Effect of CYP2C19 polymorphism on the safety and efficacy of omeprazole in Japanese patients with recurrent reflux oesophagitisAlimentary Pharmacology & Therapeutics, 2005
- Prevalence of gastroesophageal reflux disease and gastroesophageal reflux disease symptoms in JapanJournal of Gastroenterology and Hepatology, 2005
- Ambulatory 24-hour Esophageal pH MonitoringJournal of Clinical Gastroenterology, 2003
- Gastro-oesophageal reflux disease in primary careEuropean Journal of Gastroenterology & Hepatology, 1998
- Empiric therapy for gastroesophageal reflux diseaseArchives of internal medicine (1960), 1995
- Safety Experience from Long-Term Treatment with OmeprazoleDigestion, 1992